Skip to main content
Clinical Trials/NCT04240678
NCT04240678CompletedNot Applicable

The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening: A Randomized Controlled Trial

University of California, Davis0 sites8,299 target enrollmentStarted: January 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
8,299
Primary Endpoint
Serum Hepatitis B Surface Antigen Completion

Study Overview

Brief Summary

Asian and Pacific Islander Americans at risk, but never tested for chronic hepatitis B have been randomized to receive an electronic alert in their electronic medical chart to remind primary care physicians to screen them for chronic hepatitis B.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Asian and Pacific Islanders (API) who have not yet received HBsAg testing. API will be identified using a novel algorithm which identifies them using their surname, language preference, country of origin.

Exclusion Criteria

  • •Previous HBsAg completion.

Arms & Interventions

HBV Alert Group

Experimental

Intervention: Electronic HBV Alert (Other)

Control Group

No Intervention

Outcomes

Primary Outcomes

Serum Hepatitis B Surface Antigen Completion

Time Frame: up to 12 months

Number of patients who have completed the HBsAg test

Secondary Outcomes

  • Serum Hepatitis B Surface Antigen Positivity(up to 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials